# Harte Hanks Inc: financial statements, quarterly

HHS · Nasdaq · CIK 45919 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hhs.md) · [Financials](/companies/hhs/financials.md) · [Filings](/companies/hhs/filings.md) · [Insiders](/companies/hhs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hhs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [47.1](/filings/0000045919-24-000082.md) | [49.5 d](/filings/0000045919-25-000008.md) | [45.4](/filings/0000045919-25-000028.md) | [45.0](/filings/0001628280-25-039311.md) | [47.6](/filings/0001628280-25-051383.md) | [47.1 d](/filings/0001628280-26-018894.md) | [41.6](/filings/0001628280-26-035323.md) | [38.6](/filings/0000045919-26-000005.md) | [39.5](/filings/0001628280-25-051383.md) | [39.9 d](/filings/0001628280-26-018894.md) | [37.3](/filings/0001628280-26-035323.md) | [38.0](/filings/0000045919-26-000005.md) |
| Selling, general and administrative | $m | [4.9](/filings/0000045919-24-000082.md) | [4.6 d](/filings/0000045919-25-000008.md) | [5.9](/filings/0000045919-25-000028.md) | [5.9](/filings/0001628280-25-039311.md) | [5.3](/filings/0001628280-25-051383.md) | [5.7 d](/filings/0001628280-26-018894.md) | [5.8](/filings/0001628280-26-035323.md) | [5.5](/filings/0000045919-26-000005.md) | [5.1](/filings/0001628280-25-051383.md) | [5.7 d](/filings/0001628280-26-018894.md) | [5.6](/filings/0001628280-26-035323.md) | [8.8](/filings/0000045919-26-000005.md) |
| Operating income | $m | [2.9](/filings/0000045919-24-000082.md) | [(2.3) d](/filings/0000045919-25-000008.md) | [0.4](/filings/0000045919-25-000028.md) | [1.4](/filings/0001628280-25-039311.md) | [1.9](/filings/0001628280-25-051383.md) | [(1.6) d](/filings/0001628280-26-018894.md) | [(0.0)](/filings/0001628280-26-035323.md) | [0.0](/filings/0000045919-26-000005.md) | [0.5](/filings/0001628280-25-051383.md) | [(0.1) d](/filings/0001628280-26-018894.md) | [(0.8)](/filings/0001628280-26-035323.md) | [(4.5)](/filings/0000045919-26-000005.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.9](/filings/0000045919-24-000082.md) | [(2.0) d](/filings/0000045919-25-000008.md) | [(0.1)](/filings/0000045919-25-000028.md) | [(9.0)](/filings/0001628280-25-039311.md) | [0.9](/filings/0001628280-25-051383.md) | [0.6 d](/filings/0001628280-26-018894.md) | [(0.2)](/filings/0001628280-26-035323.md) | [(0.1)](/filings/0000045919-26-000005.md) | [2.6](/filings/0001628280-25-051383.md) | [(2.5) d](/filings/0001628280-26-018894.md) | [(0.4)](/filings/0001628280-26-035323.md) | [0.1](/filings/0000045919-26-000005.md) |
| Net income | $m | [0.6](/filings/0000045919-24-000082.md) | [(2.0) d](/filings/0000045919-25-000008.md) | [(0.2)](/filings/0001628280-25-051383.md) | [(27.8)](/filings/0001628280-25-051383.md) | [0.1](/filings/0001628280-25-051383.md) | [(2.4) d](/filings/0001628280-26-018894.md) | [(0.4)](/filings/0000045919-26-000005.md) | [(0.3)](/filings/0000045919-26-000005.md) | [(2.3)](/filings/0001628280-25-051383.md) | [2.2 d](/filings/0001628280-26-018894.md) | [(0.6)](/filings/0000045919-26-000005.md) | [(5.0)](/filings/0000045919-26-000005.md) |
| Diluted EPS | $ per share | [0.08](/filings/0000045919-24-000082.md) | not reported | [(0.02)](/filings/0000045919-25-000028.md) | [(3.84)](/filings/0001628280-25-039311.md) | [0.02](/filings/0001628280-25-051383.md) | not reported | [(0.05)](/filings/0001628280-26-035323.md) | [(0.05)](/filings/0000045919-26-000005.md) | [(0.31)](/filings/0001628280-25-051383.md) | not reported | [(0.08)](/filings/0001628280-26-035323.md) | [(0.67)](/filings/0000045919-26-000005.md) |
| Basic EPS | $ per share | [0.09](/filings/0000045919-24-000082.md) | not reported | [(0.02)](/filings/0000045919-25-000028.md) | [(3.84)](/filings/0001628280-25-039311.md) | [0.02](/filings/0001628280-25-051383.md) | not reported | [(0.05)](/filings/0001628280-26-035323.md) | [(0.05)](/filings/0000045919-26-000005.md) | [(0.31)](/filings/0001628280-25-051383.md) | not reported | [(0.08)](/filings/0001628280-26-035323.md) | [(0.67)](/filings/0000045919-26-000005.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.3](/filings/0000045919-24-000082.md) | [18.4](/filings/0000045919-25-000008.md) | [11.5](/filings/0000045919-25-000028.md) | [11.0](/filings/0001628280-25-039311.md) | [5.9](/filings/0001628280-25-051383.md) | [9.8](/filings/0001628280-26-018894.md) | [8.7](/filings/0001628280-26-035323.md) | [4.7](/filings/0000045919-26-000005.md) | [6.5](/filings/0001628280-25-051383.md) | [5.6](/filings/0001628280-26-018894.md) | [4.5](/filings/0001628280-26-035323.md) | [5.2](/filings/0000045919-26-000005.md) |
| Current assets | $m | [62.2](/filings/0001437749-23-031626.md) | [65.2](/filings/0000045919-25-000008.md) | [57.8](/filings/0000045919-24-000026.md) | [55.0](/filings/0000045919-24-000062.md) | [53.8](/filings/0000045919-24-000082.md) | [53.6](/filings/0001628280-26-018894.md) | [53.7](/filings/0000045919-25-000028.md) | [50.0](/filings/0001628280-25-039311.md) | [48.7](/filings/0001628280-25-051383.md) | [46.3](/filings/0000045919-26-000005.md) | [45.8](/filings/0001628280-26-035323.md) | [45.4](/filings/0000045919-26-000005.md) |
| Total assets | $m | [111](/filings/0001437749-23-031626.md) | [123](/filings/0000045919-25-000008.md) | [113](/filings/0000045919-24-000026.md) | [110](/filings/0000045919-24-000062.md) | [108](/filings/0000045919-24-000082.md) | [102](/filings/0001628280-26-018894.md) | [101](/filings/0000045919-25-000028.md) | [95.0](/filings/0001628280-25-039311.md) | [92.7](/filings/0001628280-25-051383.md) | [91.8](/filings/0000045919-26-000005.md) | [90.4](/filings/0001628280-26-035323.md) | [88.1](/filings/0000045919-26-000005.md) |
| Current liabilities | $m | [38.7](/filings/0001437749-23-031626.md) | [48.1](/filings/0000045919-25-000008.md) | [40.2](/filings/0000045919-24-000026.md) | [36.4](/filings/0000045919-24-000062.md) | [36.9](/filings/0000045919-24-000082.md) | [35.1](/filings/0001628280-26-018894.md) | [36.1](/filings/0000045919-25-000028.md) | [31.2](/filings/0001628280-25-039311.md) | [33.0](/filings/0001628280-25-051383.md) | [30.2](/filings/0000045919-26-000005.md) | [30.7](/filings/0001628280-26-035323.md) | [34.9](/filings/0000045919-26-000005.md) |
| Total liabilities | $m | [90.3](/filings/0001437749-23-031626.md) | [103](/filings/0000045919-25-000008.md) | [93.5](/filings/0000045919-24-000026.md) | [89.1](/filings/0000045919-24-000062.md) | [87.1](/filings/0000045919-24-000082.md) | [80.1](/filings/0001628280-26-018894.md) | [79.2](/filings/0000045919-25-000028.md) | [72.8](/filings/0001628280-25-039311.md) | [72.8](/filings/0001628280-25-051383.md) | [71.3](/filings/0000045919-26-000005.md) | [70.3](/filings/0001628280-26-035323.md) | [72.7](/filings/0000045919-26-000005.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000045919-26-000005.md) | not reported | [3.0](/filings/0000045919-26-000005.md) |
| Shareholders' equity | $m | [20.5](/filings/0000045919-24-000082.md) | [19.9](/filings/0001628280-26-018894.md) | [20.0](/filings/0001628280-25-051383.md) | [20.6](/filings/0001628280-25-051383.md) | [21.0](/filings/0001628280-25-051383.md) | [21.7](/filings/0000045919-26-000005.md) | [21.4](/filings/0000045919-26-000005.md) | [22.2](/filings/0000045919-26-000005.md) | [19.9](/filings/0001628280-25-051383.md) | [20.5](/filings/0000045919-26-000005.md) | [20.1](/filings/0000045919-26-000005.md) | [15.4](/filings/0000045919-26-000005.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,523 d](/filings/0000045919-24-000082.md) | [4,367 d](/filings/0000045919-25-000008.md) | [(5,692)](/filings/0000045919-25-000028.md) | [1,608 d](/filings/0001628280-25-039311.md) | [(2,948) d](/filings/0001628280-25-051383.md) | [4,045 d](/filings/0001628280-26-018894.md) | [(818)](/filings/0001628280-26-035323.md) | [(4,850) d](/filings/0000045919-26-000005.md) | [3,196 d](/filings/0001628280-25-051383.md) | [737 d](/filings/0001628280-26-018894.md) | [(575)](/filings/0001628280-26-035323.md) | [(2,072) d](/filings/0000045919-26-000005.md) |
| Capital expenditure | $k | [224 d](/filings/0000045919-24-000082.md) | [1,332 d](/filings/0000045919-25-000008.md) | [526](/filings/0000045919-25-000028.md) | [682 d](/filings/0001628280-25-039311.md) | [1,911 d](/filings/0001628280-25-051383.md) | [627 d](/filings/0001628280-26-018894.md) | [105](/filings/0001628280-26-035323.md) | [223 d](/filings/0000045919-26-000005.md) | [1,006 d](/filings/0001628280-25-051383.md) | [1,423 d](/filings/0001628280-26-018894.md) | [347](/filings/0001628280-26-035323.md) | [(41.0) d](/filings/0000045919-26-000005.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | [491 d](/filings/0000045919-24-000082.md) | [0.0 d](/filings/0000045919-25-000008.md) | not reported | not reported | [0.0 d](/filings/0000045919-24-000082.md) | [0.0 d](/filings/0000045919-25-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,524](/filings/0001437749-23-031626.md) | [7,425](/filings/0000045919-24-000026.md) | [7,505](/filings/0000045919-24-000062.md) | [7,314](/filings/0000045919-24-000082.md) | [7,236](/filings/0000045919-25-000028.md) | [7,257](/filings/0001628280-25-039311.md) | [7,398](/filings/0001628280-25-051383.md) | [7,360](/filings/0001628280-26-035323.md) | [7,382](/filings/0000045919-26-000005.md) | [7,415](/filings/0001628280-25-051383.md) | [7,416](/filings/0001628280-26-035323.md) | [7,431](/filings/0000045919-26-000005.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,454,240 at 2026-07-31, from the cover of the [10-Q filed 2026-08-14](/filings/0000045919-26-000005.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.